As PDA is almost universally driven by oncogenic KRAS and given MYC’s reported role in neuroendocrine differentiation of PCA, KRAS-induced activation of MYC may contribute to cell lineage plasticity in PDA, that could drive a neuroendocrine differentiation phenotype. The gene discussed is MYC; the disease is Patent ductus arteriosus.